Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2003
SCA2 may present as levodopa-responsive parkinsonismHaydeh Payami, John Nutt, Steven Gancher, et al.Annals of Neurology|January 7, 2015
Defining neurodegeneration on Guam by targeted genomic sequencingJohn C Steele, Ilaria Guella, Chelsea Szu-Tu, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutationsRuey-Meei Wu, Din-E Shan, Chen-Ming Sun, et al.MDM Policy & Practice|July 19, 2021
Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's DiseaseHeather L Benz, Brittany Caldwell, John P Ruiz, et al.MDM Policy & Practice|February 1, 2021
Parkinson's Patients' Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyBrett Hauber, Brennan Mange, Mo Zhou, et al.Nature Communications|August 25, 2011
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusMichael J Devine, Mina Ryten, Petr Vodicka, et al.Archives of Neurology|December 15, 2004
Genome-wide analysis of the parkinsonism-dementia complex of GuamHuw R Morris, John C Steele, Richard Crook, et al.Frontiers in Genetics|May 9, 2014
Using previously genotyped controls in genome-wide association studies (GWAS): application to the Stroke Genetics Network (SiGN)Braxton D Mitchell, Myriam Fornage, Patrick F McArdle, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 27, 2016
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortUn Jung Kang, Jennifer G Goldman, Roy N Alcalay, et al.Journal of Biopharmaceutical Statistics|March 2, 2023
Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson's diseaseShomesh E Chaudhuri, Zied Ben Chaouch, Brett Hauber, et al.Pageof 7